The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
The Apolipoprotein E Knockout Mouse: A Model Documenting Accelerated Atherogenesis In Uremia
Abstract
Rodents do not develop spontaneous atherosclerosis. Currently, there is no good animal model to study the effect of uremia on atherosclerosis. This study evaluated whether apolipoprotein E knockout (Apoe-/-) mice are useful to study the effect of renal dysfunction on cardiovascular risk. Apoe-/- mice have decreased serum apolipoprotein E and exhibit lipid abnormalities and atherosclerosis even on a low-cholesterol diet. Ten-wk-old Apoe-/- mice were subtotally nephrectomised (SNX Apoe-/-; n = 8), uninephrectomised (UNX Apoe-/-; n = 5), or sham-operated (sham Apoe-/-; n = 5) and compared with their genetic controls (SNX C57/BL6; UNX C57/BL6; sham C57/BL6). After 12 wk, BP was measured intraarterially, blood samples were taken, and the experiment was terminated by perfusion fixation. The heart weight was determined, and quantitative morphologic analysis of intramyocardial arteries and aortic changes was performed. At the end of the experiment, heart weight and relative left ventricular weight were comparable in all groups. Intraarterial BP was somewhat higher in Apoe-/- mice compared with controls. Baseline serum cholesterol and triglyceride levels were higher in Apoe-/- mice than in C57/BL6. Atherosclerotic plaques were not present in sham or UNX C57/BL6, but minor plaque formation was noted in some SNX control animals. In contrast, beginning plaques were seen even in untouched Apoe-/- mice, and strikingly increased plaque formation was noted in UNX and SNX Apoe-/- mice. Maximal plaque diameter (cross-section) was 37 +/- 74 micro m in SNX C57/BL6, 191 +/- 90 micro m in sham Apoe-/-, 323 +/- 66 micro m in UNX Apoe-/-, and 457 +/- 17 micro m in SNX Apoe-/-. The plaque morphology corresponded with that of early plaques characterized by foam cells and virtual absence of lymphocytes or smooth muscle cell infiltration. In conclusion, even mild renal dysfunction, i.e., after uninephrectomy, causes a dramatic increase in plaque size and aggressive morphology (foam cell rich soft plaques) in the animal model of the Apoe-/- mouse.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Uremia accelerates atherosclerosis and arterial calcification in patients with chronic renal failure (22,74).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [22]
Citations
Cites
Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Accelerated Atherosclerosis in Prolonged Maintenance Hemodialysis
Lindner, A., Charra, B., Sherrard, D. J., & Scribner, B. H. (1974) · New England Journal of Medicine · doi:10.1056/nejm197403282901301 · Cited by 1,772
Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D. M., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,103
Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure
Schwarz, U., Buzello, M., Ritz, E., Stein, G., Raabe, G., Wiest, G., Mall, G., & Amann, K. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.2.218 · Cited by 627
Self-citationImpaired cerebral cortex development and blood pressure regulation in FGF‐2‐deficient mice
Dono, R., Texidó, G., Dussel, R., Ehmke, H., & Zeller, R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4213 · Cited by 444
Self-citationEstimation of surface area and length with the orientator
Mattfeldt, T., Mall, G., Gharehbaghi, H., & Möller, P. (1990) · Journal of Microscopy · doi:10.1111/j.1365-2818.1990.tb03036.x · Cited by 376
Barton, M., Haudenschild, C. C., d’Uscio, L. V., Shaw, S., Münter, K., & Lüscher, T. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14367 · Cited by 356
Candido, R., Jandeleit-Dahm, K. A. M., Cao, Z., Nesteroff, S. P., Burns, W. C., Twigg, S. M., Dilley, R. J., Cooper, M. E., & Allen, T. J. (2002) · Circulation · doi:10.1161/01.cir.0000021122.63813.32 · Cited by 261
Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats
Schwarz, U., Amann, K., Orth, S. R., Simonaviciene, A., Wessels, S., & Ritz, E. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00951.x · Cited by 248
Self-citation
Cited by
Sorted by citations
Stenvinkel, P., Ketteler, M., Johnson, R. J., Lindholm, B., Pecoits‐Filho, R., RIELLA, M. C., Heimbürger, O., Cederholm, T., & Girndt, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00200.x · Cited by 952
Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease
Zeisel, S. H., & Warrier, M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064732 · Cited by 475
Media Calcification and Intima Calcification Are Distinct Entities in Chronic Kidney Disease
Amann, K. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02120508 · Cited by 395
Self-citationMeier‐Kriesche, H., Schold, J. D., Srinivas, T. R., Reed, A., & Kaplan, B. E. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00573.x · Cited by 342
Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease
Stenvinkel, P. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02269.x · Cited by 337
The heart and vascular system in dialysis
Wanner, C., Amann, K., & Shoji, T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30508-6 · Cited by 309
Self-citationThe molecular mechanisms of hemodialysis vascular access failure
Brahmbhatt, A. N., Remuzzi, A., Franzoni, M., & Misra, S. (2016) · Kidney International · doi:10.1016/j.kint.2015.12.019 · Cited by 263
Coronary Artery Disease in End-Stage Renal Disease
Stenvinkel, P., Pecoits‐Filho, R., & Lindholm, B. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000069165.79509.42 · Cited by 241
Atherosclerosis in CKD: differences from the general population
Drüeke, T. B., & Massy, Z. A. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.143 · Cited by 229
Uremia Accelerates both Atherosclerosis and Arterial Calcification in Apolipoprotein E Knockout Mice
Massy, Z. A., Ivanovski, O., Nguyen-Khoa, T., Angulo, J., Szumilak, D., Mothu, N., Phan, O., Daudon, M., Lacour, B., Dru[Combining Diaeresis]eke, T. B., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060495 · Cited by 203
Nakano, T., Ninomiya, T., Sumiyoshi, S., Fujii, H., Doi, Y., Hirakata, H., Tsuruya, K., Iida, M., Kiyohara, Y., & Sueishi, K. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.06.034 · Cited by 198
Mechanisms of uremic erythrocyte‐induced adhesion of human monocytes to cultured endothelial cells
Pandolfi, A., Pietro, N. D., Sirolli, V., Giardinelli, A., Silvestre, S. D., Amoroso, L., Tomo, P. D., Capani, F., Consoli, A., & Bonomini, M. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21138 · Cited by 185
Chronic Renal Failure Accelerates Atherogenesis in Apolipoprotein E–Deficient Mice
Bro, S., Bentzon, J. F., Falk, E., Andersen, C. B., Ølgaard, K., & Nielsen, L. B. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000088024.72216.2e · Cited by 170
Turgut, F. H., Kanbay, M., Metin, M. R., Uz, E., Akçay, A., & Covic, A. C. (2008) · International Urology and Nephrology · doi:10.1007/s11255-008-9410-3 · Cited by 167
Cross-Talk between the Kidney and the Cardiovascular System
Amann, K., Wanner, C., & Ritz, E. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006030204 · Cited by 165
Self-citationDoes Uremia Cause Vascular Dysfunction
Brunet, P., Gondouin, B., Duval-Sabatier, A., Dou, L., Cérini, C., Dignat‐George, F., Jourde‐Chiche, N., Argilés, À., & Burtey, S. (2011) · Kidney & Blood Pressure Research · doi:10.1159/000327131 · Cited by 153
Chronic Kidney Disease as a Coronary Artery Disease Risk Equivalent
Briasoulis, A., & Bakris, G. L. (2013) · Current Cardiology Reports · doi:10.1007/s11886-012-0340-4 · Cited by 152
Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice
Zhang, W., Miikeda, A., Zuckerman, J. E., Jia, X., Charugundla, S., Zhou, Z., Kaczor‐Urbanowicz, K. E., Magyar, C. E., Guo, F., Wang, Z., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80063-0 · Cited by 148
Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E–Deficient Mice
Phan, O., Ivanovski, O., Nguyen‐Khoa, T., Mothu, N., Angulo, J., Westenfeld, R., Ketteler, M., Meert, N., Maizel, J., Nikolov, I. G., et al. (2005) · Circulation · doi:10.1161/circulationaha105.541854 · Cited by 148
Calcification of Coronary Intima and Media
Gross, M., Meyer, H.-P., Ziebart, H., Rieger, P., Wenzel, U., Amann, K., Berger, I., Adamczak, M., Schirmacher, P., & Ritz, E. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01760506 · Cited by 144
Self-citationKakuta, T., Tanaka, R., Hyodo, T., Suzuki, H., Kanai, G., Nagaoka, M., Takahashi, H., Hirawa, N., Oogushi, Y., Miyata, T., et al. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.10.055 · Cited by 143
Yao, Q., Pecoits‐Filho, R., Lindholm, B., & Stenvinkel, P. (2004) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590410031715 · Cited by 139
Chronic Uremia Stimulates LDL Carbamylation and Atherosclerosis
Apostolov, E. O., Ray, D., Savenka, A. V., Shah, S. V., & Basnakian, A. G. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040365 · Cited by 132
CKD Accelerates Development of Neointimal Hyperplasia in Arteriovenous Fistulas
小久保, 拓., Ishikawa, N., Uchida, H., Chasnoff, S. E., Xie, X., Mathew, S., Hruska, K. A., & Choi, E. T. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007121312 · Cited by 125
Ritz, E., & McClellan, W. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000115398.92270.30 · Cited by 125
Self-citationIvanovski, O., Szumilak, D., Nguyen‐Khoa, T., Ruellan, N., Phan, O., Lacour, B., Descamps‐Latscha, B., Dreeke, T. B., & Massy, Z. A. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00332.x · Cited by 117
Lim, R. S., Suhalim, J. L., Miyazaki‐Anzai, S., Miyazaki, M., Levi, M., Potma, E. O., & Tromberg, B. J. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m018077 · Cited by 110
Vascular Calcification in Chronic Renal Failure
Neven, E., & D’Haese, P. C. (2011) · Circulation Research · doi:10.1161/circresaha.110.225904 · Cited by 101
Hypoxia and Expression of Hypoxia-Inducible Factor in the Aging Kidney
Tanaka, T., Kato, H., Kojima, I., Ohse, T., Son, D., Tawakami, T., Yatagawa, T., Inagi, R., Fujita, T., & Nangaku, M. (2006) · The Journals of Gerontology Series A · doi:10.1093/gerona/61.8.795 · Cited by 97
The role of the kidney in lipid metabolism
Moestrup, S. K., & Nielsen, L. B. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000169350.45944.d4 · Cited by 98
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
Koleganova, N., Piecha, G., Ritz, E., Schmitt, C. P., & Gross, M. (2008) · Kidney International · doi:10.1038/ki.2008.490 · Cited by 97
Self-citationHyperlipidemia induces meibomian gland dysfunction
Bu, J., Wu, Y., Cai, X., Jiang, N., Jeyalatha, M. V., Yu, J., He, X., He, H., Guo, Y., Zhang, M., et al. (2019) · The Ocular Surface · doi:10.1016/j.jtos.2019.06.002 · Cited by 96
Atherosclerosis in chronic kidney disease: the role of macrophages
Kon, V., Linton, M. F., & Fazio, S. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.157 · Cited by 89
Drechsler, C., Kalim, S., Wenger, J., Suntharalingam, P., Hod, T., Thadhani, R., Karumanchi, S. A., Wanner, C., & Berg, A. H. (2015) · Kidney International · doi:10.1038/ki.2014.429 · Cited by 88
Increased Infarct Size in Uremic Rats
Dikow, R., Kihm, L., Zeier, M. G., Kapitza, J., Diaeresis]rnig, J. T., Amann, K., Tiefenbacher, C., & Ritz, E. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000130154.42061.c6 · Cited by 83
Self-citationAtherosclerosis and Vascular Calcification in Chronic Renal Failure
Câmpean, V., Neureiter, D., Varga, I., Runk, F., Reiman, A., Garlichs, C., Achenbach, S., Nonnast-Daniel, B., & Amann, K. (2005) · Kidney & Blood Pressure Research · doi:10.1159/000090182 · Cited by 83
Self-citationBro, S., Moeller, F., Andersen, C. B., Ølgaard, K., & Nielsen, L. B. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000128371.33195.7b · Cited by 78
Kuo, K., Hung, S., Lee, T., & Tarng, D. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080838 · Cited by 78
Lim, R. S., Kratzer, A., Barry, N. P., Miyazaki‐Anzai, S., Miyazaki, M., Mantulin, W. W., Levi, M., Potma, E. O., & Tromberg, B. J. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003616 · Cited by 75
LDL cholesterol in CKD—to treat or not to treat?
Massy, Z. A., & de Zeeuw, D. (2013) · Kidney International · doi:10.1038/ki.2013.181 · Cited by 72
Pinkau, T., Hilgers, K. F., Veelken, R. A., & Mann, J. F. E. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000107565.17553.71 · Cited by 62
Lipid Abnormalities and Cardiovascular Risk in Renal Disease
Ritz, E., & Wanner, C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101128 · Cited by 54
Self-citationLipid Changes and Statins in Chronic Renal Insufficiency
Ritz, E., & Wanner, C. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080919 · Cited by 52
Self-citationBro, S., Flyvbjerg, A., Binder, C. J., Bang, C. A., Denner, L. A., Ølgaard, K., & Nielsen, L. B. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.01.015 · Cited by 52
Zhang, H., Zhang, A., Kohan, D. E., Nelson, R. D., Gonzales, F., & Yang, T. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090935 · Cited by 50
Heart and Kidney: Fatal Twins?
Ritz, E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.012 · Cited by 48
Self-citationBecker, L. E., Koleganova, N., Piecha, G., Noronha, I. L., Zeier, M., Geldyyev, A., Kökény, G., Ritz, E., & Gross, M. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00042.2010 · Cited by 47
Self-citationExpression of Apolipoprotein B in the Kidney Attenuates Renal Lipid Accumulation
Krzystanek, M., Pedersen, T. X., Bartels, E. D., Kjæhr, J., Straarup, E. M., & Nielsen, L. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.078006 · Cited by 46
Why is coronary heart disease of uraemic patients so frequent and so devastating?
Amann, K., Ritz, C., Adamczak, M., & Ritz, E. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg059 · Cited by 45
Self-citationVascular Damage in Kidney Disease: Beyond Hypertension
Stinghen, A. E. M., & Pecoits‐Filho, R. (2011) · International Journal of Hypertension · doi:10.4061/2011/232683 · Cited by 43
Pleiotropic effects of the non-calcium phosphate binder sevelamer
Nikolov, I. G., Joki, N., Maizel, J., Lacour, B., Drüeke, T. B., & Massy, Z. A. (2006) · Kidney International · doi:10.1038/sj.ki.5001994 · Cited by 42
Nakano, T., Ninomiya, T., Sumiyoshi, S., Onimaru, M., Fujii, H., Itabe, H., Nakashima, Y., Sueishi, K., Tsuruya, K., Oda, Y., et al. (2013) · Kidney International · doi:10.1038/ki.2013.111 · Cited by 41
Ge, S., Hertel, B., Koltsova, E. K., Sörensen-Zender, I., Kielstein, J. T., Ley, K. F., Haller, H. G., & von Vietinghoff, S. (2013) · Circulation Research · doi:10.1161/circresaha.113.301934 · Cited by 41
Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy
Hinder, L. M., Vincent, A. M., Hayes, J. M., McLean, L. L., & Feldman, E. L. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.10.002 · Cited by 43
Matsumoto, T., d’Uscio, L. V., Eguchi, D., Akiyama, M., Smith, L. A., & Katušić, Z. S. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049163 · Cited by 40
Pathophysiology Underlying Accelerated Atherogenesis in Renal Disease
Amann, K., Gross, M., & Ritz, E. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000128365.76153.5b · Cited by 40
Self-citationDecreased expression of klotho gene in uremic atherosclerosis in apolipoprotein E-deficient mice
Yu, J., Deng, M., Zhao, J., & Huang, L. J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.046 · Cited by 39
Tomayko, E. J., Cachia, A. J., Chung, H. R., & Wilund, K. R. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2012.0219 · Cited by 36
T Cell CX3CR1 Mediates Excess Atherosclerotic Inflammation in Renal Impairment
Dong, L., Nordlohne, J., Ge, S., Hertel, B., Melk, A., Rong, S., Haller, H. G., & von Vietinghoff, S. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050540 · Cited by 36
Antiatherogenic Effects of Angiotensin Receptor Antagonism in Mild Renal Dysfunction
Suganuma, E., Zuo, Y., Ayabe, N., Ma, J., Babaev, V. R., Linton, M. F., Fazio, S., Ichikawa, I., Fogo, A. B., & Kon, V. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080883 · Cited by 33
Bro, S., Binder, C. J., Witztum, J. L., Ølgaard, K., & Nielsen, L. B. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.139634 · Cited by 32
Basnakian, A. G., Shah, S. V., Ok, E., Altunel, E., & Apostolov, E. O. (2010) · Advances in clinical chemistry · doi:10.1016/s0065-2423(10)51002-3 · Cited by 33
Bro, S., Borup, R., Andersen, C. B., Moeller, F., Ølgaard, K., & Nielsen, L. B. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000201060.47945.cb · Cited by 30
Ni, J., Ma, K., Wang, C.-X., Liu, J., Zhang, Y., Lv, L., Ni, H.-F., Chen, Y.-X., Ruan, X. Z., & Liu, B. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-49 · Cited by 29
The Role of Vascular Calcification in Heart Failure and Cognitive Decline
Cheng, H., Wang, J., & Chen, C. (2017) · Pulse · doi:10.1159/000484941 · Cited by 29
Wu-Wong, J. R., Nakane, M., Ma, J., Ruan, X., & Kroeger, P. E. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00492.2006 · Cited by 28
Losada, M. E. O., Loughlin, S. M., Rodríguez-Granillo, G. A., Müller, A., Ottaviano, G., Moriondo, M., Cutrìn, J. C., & Milei, J. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-57 · Cited by 28
Ghosh, S. S., Righi, S., Krieg, R. J., Kang, L., Carl, D. E., Wang, J., Massey, H. D., Sica, D. A., Gehr, T. W. B., & Ghosh, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141109 · Cited by 28
Renal function is associated with risk of atrial fibrillation after cardiac surgery
Auer, J., Lamm, G., Weber, T., Berent, R., Ng, C., Porodko, M., & Eber, B. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)70839-5 · Cited by 28
Review: Apolipoprotein E (Apo E) gene polymorphism and coronary heart disease in Asian populations.
Yousuf, F. A., & Iqbal, M. P. (2015) · PubMed · Cited by 27
Extracellular vesicles as mediators of vascular inflammation in kidney disease
Helmke, A., & von Vietinghoff, S. (2016) · World Journal of Nephrology · doi:10.5527/wjn.v5.i2.125 · Cited by 28
Chen, W.-J., Lai, Y., Lee, J.-L., Wu, S., & Hsu, Y. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.11.009 · Cited by 26
Câmpean, V., Neureiter, D., Nonnast-Daniel, B., Garlichs, C. D., Gross, M., & Amann, K. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.01.014 · Cited by 26
Self-citationWhy Do Dialysis Patients Develop a Heart of Stone and Bone of China?
Martola, L., Barany, P. F., & Stenvinkel, P. (2005) · Blood Purification · doi:10.1159/000084890 · Cited by 26
Li, T., Shi, Y., Yin, J., Qin, Q., Wei, S., Nie, S., & Liu, L. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0843-6 · Cited by 24
Dyslipidemia in chronic kidney disease: pathogenesis and intervention
Piecha, G., Adamczak, M., & Ritz, E. (2009) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.745 · Cited by 24
Self-citationAtherosclerosis in Dialyzed Patients
Ritz, E. (2004) · Blood Purification · doi:10.1159/000074921 · Cited by 24
Self-citationReducing lipids for CV protection in CKD patients—current evidence
Wanner, C., & Ritz, E. (2008) · Kidney International · doi:10.1038/ki.2008.520 · Cited by 23
Self-citationBuzello, M., Haas, C. S., Hauptmann, F., Gross, M.-L., Faulhaber, J. D., Schultze–Mosgau, S., Ehmke, H., Ritz, E., & Amann, K. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg578 · Cited by 23
Self-citationRenal dysfunction as a novel risk factor: Microalbuminuria and cardiovascular risk
Ritz, E. (2004) · Kidney International · doi:10.1111/j.1523-1755.2005.09306.x · Cited by 23
Self-citationProgression of renal disease: new insights into risk factors and pathomechanisms
Gross, M., & Amann, K. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200405000-00007 · Cited by 23
Self-citationPedersen, T. X., Bro, S., Andersen, M. H., Etzerodt, M., Jauhiainen, M., Moestrup, S., & Nielsen, L. B. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.041 · Cited by 22
González, J., Donoso, W., Sandoval, N., Reyes, M., Gonzalez, P., Gajardo, M., Morales, E., Neira, A., Razmilic, I., Yuri, J. A., et al. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/918384 · Cited by 22
Voluntary Exercise Decreases Atherosclerosis in Nephrectomised ApoE Knockout Mice
Shing, C. M., Fassett, R. G., Peake, J. M., & Coombes, J. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120287 · Cited by 22
Pathophysiology of Cardiovascular Disease and Renal Failure
Dikow, R., Zeier, M. G., & Ritz, E. (2005) · Cardiology Clinics · doi:10.1016/j.ccl.2005.03.002 · Cited by 22
Self-citationOsteopontin deficiency dampens the pro-atherogenic effect of uraemia
Pedersen, T. X., Madsen, M., Junker, N., Christoffersen, C., Vikeså, J., Bro, S., Hultgårdh‐Nilsson, A., & Nielsen, L. B. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt049 · Cited by 20
Łysek-Gładysińska, M., Wieczorek, A., Jóźwik, A., Walaszczyk, A., Jelonek, K., Szczukiewicz-Markowska, G., Horbańczuk, O. K., Pietrowska, M., Widłak, P., & Gabryś, D. (2021) · Cells · doi:10.3390/cells10030502 · Cited by 19
Increased Calcification and Protein Nitration in Arteries of Chronic Kidney Disease Patients
Guilgen, G., Werneck, M. L., de Noronha, L., Martins, A. P. C., Varela, A., Nakao, L. S., & Pecoits‐Filho, R. (2011) · Blood Purification · doi:10.1159/000330327 · Cited by 19
Lipoprotein(a) accelerates atherosclerosis in uremic mice
Pedersen, T. X., McCormick, S. P. A., Tsimikas, S., Bro, S., & Nielsen, L. B. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m006742 · Cited by 19
Moderate kidney disease inhibits atherosclerosis regression
Ponda, M. P., Barash, I., Feig, J. E., Fisher, E. A. A., & Skolnik, E. Y. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.10.029 · Cited by 18
Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice
Nikolov, I. G., Joki, N., Galmiche, A., Nguyen‐Khoa, T., Guerrera, I. C., Guillonneau, F., Ivanovski, O., Phan, O., Maizel, J., Marçon, F., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.02.041 · Cited by 18
Cardiovascular risk in diabetic end-stage renal disease patients
Wang, A. Y.-M. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00113.x · Cited by 19
Kostogrys, R. B., Johann, C., Czyżyńska-Cichoń, I., Franczyk‐Żarów, M., Drahun, A., Maślak, E., Jasztal, A., Gajda, M., Mateuszuk, Ł., Wróbel, T. P., et al. (2015) · The journal of nutrition health & aging · doi:10.1007/s12603-015-0543-7 · Cited by 17
Management of acute intradialytic cardiovascular complications: Updated overview (Review)
Timofte, D., Tănăsescu, M., Balan, D., Tulin, A., Știru, O., Vacaroiu, I., Mihai, A., Popa, C., Cosconel, C.-I., Enyedi, M., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9713 · Cited by 15
Kidney complications: Why don't statins always work?
Karumanchi, S. A., & Thadhani, R. (2010) · Nature Medicine · doi:10.1038/nm0110-38 · Cited by 15
Effect of uremia on HDL composition, vascular inflammation, and atherosclerosis in wild-type mice
Bang, C. A., Bro, S., Bartels, E. D., Pedersen, T. X., & Nielsen, L. B. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00039.2007 · Cited by 14
Cardiac structure and function in a mouse model of uraemia without hypertension
Bro, S., Bollano, E., Brüel, A., Ølgaard, K., & Nielsen, L. B. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510802037272 · Cited by 13
Shing, C. M., Fassett, R. G., Peake, J. M., & Coombes, J. S. (2014) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12096 · Cited by 13
Gut microbiota-derived metabolite trimethylamine-N-oxide and stroke outcome: a systematic review
Zhang, P., Wang, R., Qu, Y., Guo, Z., & Yang, Y. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1165398 · Cited by 10
Atherosclerosis and vascular calcification in uraemia - a new experimental model.
Ivanovski, O., Nikolov, I. G., Drueke, B. T., & Massy, A. Z. (2007) · PubMed · Cited by 12
Metadata
- Authors
- Buzello, M., Törnig, J., Faulhaber, J., Ehmke, H., Ritz, E., & Amann, K.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Heidelberg University (DE)
- Corresponding author
- Amann, Kerstin
- Venue
- Journal of the American Society of Nephrology
- Published
- 2003-02
- Volume
- 14
- Issue
- 2
- Pages
- 311-316
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2139687501
- Cited by
- 167
- References
- 16
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 18 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 9 · 2014: 8 · 2013: 13 · 2012: 2
- FWCI
- 4.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Else Kröner-Fresenius-Stiftung
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- ApoE-deficient mice, atherosclerosis, renal dysfunction, unilateral nephrectomy, subtotal nephrectomy, uremia, atherosclerotic plaque formation, plaque morphology, foam cells, serum cholesterol, triglycerides, blood pressure, cardiovascular risk, cholesterol-lowering diet, lipid metabolism disorders, heart weight, left ventricular hypertrophy
- MeSH terms
- Animals, Apolipoproteins E, Arteries, Arteriosclerosis, Blood Pressure, Elasticity, Mice, Inbred C57BL, Nephrectomy, Time Factors, Uremia, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review